Journal of Medical Economics, Volume 18, Issue 11 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 18, Issue 11 (2015)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Volume 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Miscellany

Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement
Stavros Petrou, Oliver Rivero-Arias, Helen Dakin, Louise Longworth, Mark Oppe, Robert Froud & Alastair Gray
Pages: 851-857
Published online: 30 Jul 2015
AbstractforPreferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement | Full Text | References | PDF (80.8 KB)
  • 963 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Letter to the Editor

Letter
Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson’s Disease in the UK and Germany
Gillian Barnett & Adrian C. Williams
Pages: 858-859
Published online: 21 Jul 2015
CitationforRe: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson’s Disease in the UK and Germany | Full Text | References | PDF (50.3 KB)
  • 762 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Letter to the editor

Letter
Reply: Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson’s Disease in the UK and Germany
Evelyn Walter & Per Odin
Pages: 860-862
Published online: 27 Jul 2015
First Page PreviewforReply: Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson’s Disease in the UK and Germany | Full Text | References | PDF (54.6 KB)
  • 959 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Impact of initiation of asenapine on patterns of utilization and cost of healthcare resources associated with the treatment of bipolar I disorder
Abhishek Chitnis, Rosa Wang, Shawn X. Sun, Shailja Dixit, Alie Tawah & Luke Boulanger
Pages: 863-870
Published online: 26 Aug 2015
AbstractforImpact of initiation of asenapine on patterns of utilization and cost of healthcare resources associated with the treatment of bipolar I disorder | Full Text | References | PDF (89.4 KB)
  • 416 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
The need for cost-effective choices to treat patients with bipolar 1 disorders including asenapine
Brian Godman
Pages: 871-873
Published online: 26 Aug 2015
AbstractforThe need for cost-effective choices to treat patients with bipolar 1 disorders including asenapine | Full Text | References | PDF (56.7 KB)
  • 462 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England
Maciej J. Maruszczak, Stephen M. Montgomery, Matthew J. S. Griffiths, Niklas Bergvall & Nicholas Adlard
Pages: 874-885
Published online: 01 Jul 2015
AbstractforCost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England | Full Text | References | PDF (670.3 KB) | Supplemental
  • 1557 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access
Article
Modeling the clinical and economic implications of obesity using microsimulation
W. Su, J. Huang, F. Chen, W. Iacobucci, M. Mocarski, T. M. Dall & L. Perreault
Pages: 886-897
Published online: 13 Aug 2015
AbstractforModeling the clinical and economic implications of obesity using microsimulation | Full Text | References | PDF (284.9 KB)
  • 2943 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access
Article
Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor
Cliff Molife, Feride Frech-Tamas, Mitch DeKoven, Mark B. Effron, Swapna Karkare, Yajun Zhu, Cynthia Larmore, Jingsong Lu, Patrick McCollam, Elizabeth Marrett & George W. Vetrovec
Pages: 898-908
Published online: 10 Jul 2015
AbstractforComparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor | Full Text | References | PDF (286.1 KB) | Supplemental
  • 837 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
Budget impact model of a 5-grass sublingual immunotherapy tablet for the treatment of grass pollen-induced allergic rhinitis
Jasmina I. Ivanova, Sneha Kelkar, Sarah King, Howard G. Birnbaum, Sue Hocker, Robert Phipps & Richard Lankow
Pages: 909-918
Published online: 06 Jul 2015
AbstractforBudget impact model of a 5-grass sublingual immunotherapy tablet for the treatment of grass pollen-induced allergic rhinitis | Full Text | References | PDF (196.5 KB)
  • 482 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Health resource use and costs of vilazodone and other selective serotonin re-uptake inhibitors in treating major depressive disorder
Zheng-Yi Zhou, Shawn Sun, Pooja Chopra, Yichen Zhong, Todor Totev & James Signorovitch
Pages: 919-929
Published online: 06 Jul 2015
AbstractforHealth resource use and costs of vilazodone and other selective serotonin re-uptake inhibitors in treating major depressive disorder | Full Text | References | PDF (319.3 KB)
  • 624 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer’s type in the US
Catherine Saint-Laurent Thibault, Ipek Özer Stillman, Stephanie Chen, Denis Getsios, Irina Proskorovsky, Luis Hernandez & Shailja Dixit
Pages: 930-943
Published online: 26 Aug 2015
AbstractforCost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer’s type in the US | Full Text | References | PDF (391.9 KB) | Supplemental
  • 1753 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access
Article
A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis
Michelle M. A. Kip, Ron Kusters, Maarten J. IJzerman & Lotte M. G. Steuten
Pages: 944-953
Published online: 20 Jul 2015
AbstractforA PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis | Full Text | References | PDF (356.3 KB) | Supplemental
  • 2054 Views
  • 38 CrossRef citations
  • 0Altmetric
Free Access

Review

Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review
Gebra Cuyun Carter, Denise T. King, Lisa M. Hess, Stephen A. Mitchell, Kaisa-Leena Taipale, Urpo Kiiskinen, Narayan Rajan, Diego Novick & Astra M. Liepa
Pages: 954-966
Published online: 27 Jul 2015
AbstractforHealth state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review | Full Text | References | PDF (193.6 KB) | Supplemental
  • 1232 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Healthcare costs of pregnancy in systemic lupus erythematosus: retrospective observational analysis from a US health claims database
M. Petri, R. P. Daly & D. S. Pushparajah
Pages: 967-973
Published online: 14 Aug 2015
AbstractforHealthcare costs of pregnancy in systemic lupus erythematosus: retrospective observational analysis from a US health claims database | Full Text | References | PDF (363.7 KB) | Supplemental
  • 998 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness analysis of exenatide twice daily (BID) vs insulin glargine once daily (QD) as add-on therapy in Chinese patients with Type 2 diabetes mellitus inadequately controlled by oral therapies
Jing Deng, Shuyan Gu, Hui Shao, Hengjin Dong, Dajin Zou & Lizheng Shi
Pages: 974-989
Published online: 20 Aug 2015
AbstractforCost-effectiveness analysis of exenatide twice daily (BID) vs insulin glargine once daily (QD) as add-on therapy in Chinese patients with Type 2 diabetes mellitus inadequately controlled by oral therapies | Full Text | References | PDF (341.9 KB)
  • 960 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Explore articles